PTC Therapeutics Inc (NASDAQ: PTCT) established initial surge of 4.00% at $86.25, as the Stock market unbolted on Thursday, before settling in for the price of $82.93 at the close. Taking a more long-term approach, PTCT posted a 52-week range of $35.95-$85.61.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -2.04%. Meanwhile, its Annual Earning per share during the time was -2.04%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 299.15%. This publicly-traded company’s shares outstanding now amounts to $79.93 million, simultaneously with a float of $77.16 million. The organization now has a market capitalization sitting at $6.92 billion. At the time of writing, stock’s 50-day Moving Average stood at $68.42, while the 200-day Moving Average is $54.52.
PTC Therapeutics Inc (PTCT) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the PTC Therapeutics Inc industry. PTC Therapeutics Inc’s current insider ownership accounts for 3.90%, in contrast to 102.94% institutional ownership. According to the most recent insider trade that took place on Nov 25 ’25, this organization’s CHIEF TECHNICAL OPS OFFICER sold 71,928 shares at the rate of 83.44, making the entire transaction reach 6,001,932 in total value, affecting insider ownership by 100,625. Preceding that transaction, on Nov 24 ’25, Company’s CHIEF TECHNICAL OPS OFFICER sold 35,572 for 80.18, making the whole transaction’s value amount to 2,852,031. This particular insider is now the holder of 100,625 in total.
PTC Therapeutics Inc (PTCT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.09 per share during the current fiscal year. PTC Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 299.15% and is forecasted to reach -1.03 in the upcoming year.
PTC Therapeutics Inc (NASDAQ: PTCT) Trading Performance Indicators
Let’s observe the current performance indicators for PTC Therapeutics Inc (PTCT). It’s Quick Ratio in the last reported quarter now stands at 2.26. Alongside those numbers, its PE Ratio stands at $10.08, and its Beta score is 0.45. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.89. Similarly, its price to free cash flow for trailing twelve months is now 9.82.
In the same vein, PTCT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 8.56, a figure that is expected to reach -0.41 in the next quarter, and analysts are predicting that it will be -1.03 at the market close of one year from today.
Technical Analysis of PTC Therapeutics Inc (PTCT)
Now, what If we examine the latest scores posted by [PTC Therapeutics Inc, PTCT]. During the last 5-days, its volume was better the volume of 1.2 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 83.86% While, its Average True Range was 91.44.
Raw Stochastic average of PTC Therapeutics Inc (PTCT) in the period of the previous 100 days is set at 97.18%, which indicates a major rise in contrast to 93.16% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 2.87 that was higher than 2.28 volatility it exhibited in the past 100-days period.
